These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 16918396

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions.
    Tarazi FI, Zhang K, Baldessarini RJ.
    Psychopharmacology (Berl); 2002 May; 161(3):263-70. PubMed ID: 12021829
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
    Moran-Gates T, Massari C, Graulich A, Liégeois JF, Tarazi FI.
    J Neurosci Res; 2006 Aug 15; 84(3):675-82. PubMed ID: 16810690
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptors.
    Bortolozzi A, Masana M, Díaz-Mataix L, Cortés R, Scorza MC, Gingrich JA, Toth M, Artigas F.
    Int J Neuropsychopharmacol; 2010 Nov 15; 13(10):1299-314. PubMed ID: 20158933
    [Abstract] [Full Text] [Related]

  • 13. Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT.
    Dekeyne A, Rivet JM, Gobert A, Millan MJ.
    Neuropharmacology; 2001 Jun 15; 40(7):899-910. PubMed ID: 11378160
    [Abstract] [Full Text] [Related]

  • 14. Atypical antipsychotics: matching receptor profile to individual patient's clinical profile.
    Shayegan DK, Stahl SM.
    CNS Spectr; 2004 Oct 15; 9(10 Suppl 11):6-14. PubMed ID: 15475871
    [Abstract] [Full Text] [Related]

  • 15. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
    Kuroki T, Nagao N, Nakahara T.
    Prog Brain Res; 2008 Oct 15; 172():199-212. PubMed ID: 18772034
    [Abstract] [Full Text] [Related]

  • 16. Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors.
    Cussac D, Duqueyroix D, Newman-Tancredi A, Millan MJ.
    Psychopharmacology (Berl); 2002 Jul 15; 162(2):168-77. PubMed ID: 12110994
    [Abstract] [Full Text] [Related]

  • 17. Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties.
    Rauly-Lestienne I, Boutet-Robinet E, Ailhaud MC, Newman-Tancredi A, Cussac D.
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Oct 15; 376(1-2):93-105. PubMed ID: 17786406
    [Abstract] [Full Text] [Related]

  • 18. Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats.
    Oyamada Y, Horiguchi M, Rajagopal L, Miyauchi M, Meltzer HY.
    Behav Brain Res; 2015 May 15; 285():165-75. PubMed ID: 25448429
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.